MLYS logo

Mineralys Therapeutics (MLYS) Enterprise Value

Enterprise Value

$793.34 M
+$60.28 M+8.22%

Fri, 14 Mar 2025 23:56:55 GMT


Summary


Performance

MLYS Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherMLYSvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

MLYS Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday+8.2%+7.1%+7.1%
1 m1 month+100.2%+77.8%+41.1%
3 m3 months+60.3%+53.2%+21.4%
6 m6 months+57.4%+58.7%+25.6%
ytdytd+58.9%+48.0%+17.4%
1 y1 year+38.3%+45.7%+14.7%
5 y5 years---

MLYS Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-monthat high$314 M+152.3%
3 m3-month$793 Mat high$314 M+152.3%
6 m6-month$793 Mat high$314 M+152.3%
1 y1-year$793 Mat high$314 M+152.3%
3 y3-year$793 Mat high$155 M+413.2%
5 y5-year$793 Mat high$155 M+413.2%
alltimeall time$793 Mat high$155 M+413.2%

Mineralys Therapeutics Enterprise Value History

DateValue
2025
$793.34 M(+58.9%)
DateValue
2024
$499.22 M(+64.0%)
2023
$304.45 M

FAQ

  • What is Mineralys Therapeutics enterprise value?
  • What is the all time high enterprise value for Mineralys Therapeutics?
  • What is MLYS enterprise value year-to-date change?
  • What is Mineralys Therapeutics enterprise value year-on-year change?

What is Mineralys Therapeutics enterprise value?

The current enterprise value of MLYS is $793.34 M

What is the all time high enterprise value for Mineralys Therapeutics?

Mineralys Therapeutics all-time high enterprise value is $793.34 M

What is MLYS enterprise value year-to-date change?

Mineralys Therapeutics enterprise value has changed by +$294.13 M (+58.92%) since the beginning of the year

What is Mineralys Therapeutics enterprise value year-on-year change?

Over the past year, MLYS enterprise value has changed by +$219.65 M (+38.29%)